Clinical Trial Update: Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and effectiveness of dupilumab for atopic dermatitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: COMPLETED | Results posted: 2020-03-18